Titan Biotech allots 1,03,29,625 bonus shares at a 1-for-4 ratio
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.1 pts less than Nifty Microcap 250 and 3.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board approved allotment of 1,03,29,625 fully paid bonus shares of Rs. 2 each to shareholders on the October 23, 2026 record date. The ratio is 1 new share for every 4 existing shares, following shareholder approval on September 29, 2026. Paid-up capital rises from Rs. 8.26 crore to Rs. 10.33 crore, while total shares rise from 4.13 crore to 5.16 crore. Shares will be credited within the required time.
Share count and paid-up capital rise proportionately. Existing ownership percentages stay unchanged; the bonus adds no cash and does not change total earnings.